Global Parkinson’s Disease Therapeutics Market Research Report 2025(Status and Outlook)
Report Overview
Parkinson's disease therapeutics includes medications and therapies used to manage the symptoms of Parkinson's disease, a neurodegenerative disorder that affects movement and motor control.
This report provides a deep insight into the global Parkinson’s Disease Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Parkinson’s Disease Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Parkinson’s Disease Therapeutics market in any manner.
Global Parkinson’s Disease Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbvie
Biogen
Boehringer Ingelheim GmbH
F. Hoffman-La Roche
GlaxoSmithKline
H. Lundbeck A/S
Impax Labs
Newron Pharmaceuticals SpA
Novartis AG
Orion Corporation
Teva Pharmaceutical Industries Ltd.
UCB S.A.
Livzon Pharmaceutical
Haisco Pharmaceutical
Jingxin Pharmaceutical
Dongcheng Biochemicals
Market Segmentation (by Type)
Oral
Transdermal
Subcutaneous
Intestinal Infusion
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Parkinson’s Disease Therapeutics Market
- Overview of the regional outlook of the Parkinson’s Disease Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Parkinson’s Disease Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Parkinson’s Disease Therapeutics
1.2 Key Market Segments
1.2.1 Parkinson’s Disease Therapeutics Segment by Type
1.2.2 Parkinson’s Disease Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLOBAL PARKINSON’S DISEASE THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Parkinson’s Disease Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Parkinson’s Disease Therapeutics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLOBAL PARKINSON’S DISEASE THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Parkinson’s Disease Therapeutics Product Life Cycle
3.3 Global Parkinson’s Disease Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Parkinson’s Disease Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Parkinson’s Disease Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Parkinson’s Disease Therapeutics Manufacturing Sites, Area Served, Product Type
3.8 Parkinson’s Disease Therapeutics Market Competitive Situation and Trends
3.8.1 Parkinson’s Disease Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Parkinson’s Disease Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PARKINSON’S DISEASE THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Parkinson’s Disease Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PARKINSON’S DISEASE THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Parkinson’s Disease Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Parkinson’s Disease Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 GLOBAL PARKINSON’S DISEASE THERAPEUTICS MARKET BY REGION
6.1 Global Parkinson’s Disease Therapeutics Market Size by Region
6.1.1 Global Parkinson’s Disease Therapeutics Market Size by Region
6.1.2 Global Parkinson’s Disease Therapeutics Market Size Market Share by Region
6.2 Global Parkinson’s Disease Therapeutics Sales by Region
6.2.1 Global Parkinson’s Disease Therapeutics Sales by Region
6.2.2 Global Parkinson’s Disease Therapeutics Sales Market Share by Region
7 NORTH AMERICA MARKET OVERVIEW
7.1 North America Parkinson’s Disease Therapeutics Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Parkinson’s Disease Therapeutics Market Size by Type
7.3 North America Parkinson’s Disease Therapeutics Market Size by Application
8 EUROPE MARKET OVERVIEW
8.1 Europe Parkinson’s Disease Therapeutics Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Parkinson’s Disease Therapeutics Market Size by Type
8.3 Europe Parkinson’s Disease Therapeutics Market Size by Application
9 ASIA-PACIFIC MARKET OVERVIEW
9.1 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Type
9.3 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Application
10 SOUTH AMERICA MARKET OVERVIEW
10.1 South America Parkinson’s Disease Therapeutics Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Parkinson’s Disease Therapeutics Market Size by Type
10.3 South America Parkinson’s Disease Therapeutics Market Size by Application
11 MIDDLE EAST AND AFRICA MARKET OVERVIEW
11.1 Middle East and Africa Parkinson’s Disease Therapeutics Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Parkinson’s Disease Therapeutics Market Size by Type
11.3 Middle East and Africa Parkinson’s Disease Therapeutics Market Size by Application
12 PARKINSON’S DISEASE THERAPEUTICS MARKET PRODUCTION BY REGION
12.1 Global Production of Parkinson’s Disease Therapeutics by Region(2020-2025)
12.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Region (2020-2025)
12.3 Global Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Parkinson’s Disease Therapeutics Production
12.4.1 North America Parkinson’s Disease Therapeutics Production Growth Rate (2020-2025)
12.4.2 North America Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Parkinson’s Disease Therapeutics Production
12.5.1 Europe Parkinson’s Disease Therapeutics Production Growth Rate (2020-2025)
12.5.2 Europe Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Parkinson’s Disease Therapeutics Production (2020-2025)
12.6.1 Japan Parkinson’s Disease Therapeutics Production Growth Rate (2020-2025)
12.6.2 Japan Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Parkinson’s Disease Therapeutics Production (2020-2025)
12.7.1 China Parkinson’s Disease Therapeutics Production Growth Rate (2020-2025)
12.7.2 China Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
13 PARKINSON’S DISEASE THERAPEUTICS MARKET SEGMENTATION BY TYPE
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Parkinson’s Disease Therapeutics Sales Market Share by Type (2020-2033)
13.3 Global Parkinson’s Disease Therapeutics Market Size Market Share by Type (2020-2033)
13.4 Global Parkinson’s Disease Therapeutics Price by Type (2020-2033)
14 PARKINSON’S DISEASE THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Parkinson’s Disease Therapeutics Market Sales by Application (2020-2033)
14.3 Global Parkinson’s Disease Therapeutics Market Size (M USD) by Application (2020-2033)
14.4 Global Parkinson’s Disease Therapeutics Sales Growth Rate by Application (2020-2033)
15 KEY COMPANIES PROFILE
15.1 Abbvie
15.1.1 Abbvie Basic Information
15.1.2 Abbvie Parkinson’s Disease Therapeutics Product Overview
15.1.3 Abbvie Parkinson’s Disease Therapeutics Product Market Performance
15.1.4 Abbvie Business Overview
15.1.5 Abbvie SWOT Analysis
15.1.6 Abbvie Recent Developments
15.2 Biogen
15.2.1 Biogen Basic Information
15.2.2 Biogen Parkinson’s Disease Therapeutics Product Overview
15.2.3 Biogen Parkinson’s Disease Therapeutics Product Market Performance
15.2.4 Biogen Business Overview
15.2.5 Biogen SWOT Analysis
15.2.6 Biogen Recent Developments
15.3 Boehringer Ingelheim GmbH
15.3.1 Boehringer Ingelheim GmbH Basic Information
15.3.2 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Overview
15.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Market Performance
15.3.4 Boehringer Ingelheim GmbH Business Overview
15.3.5 Boehringer Ingelheim GmbH SWOT Analysis
15.3.6 Boehringer Ingelheim GmbH Recent Developments
15.4 F. Hoffman-La Roche
15.4.1 F. Hoffman-La Roche Basic Information
15.4.2 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Overview
15.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Market Performance
15.4.4 F. Hoffman-La Roche Business Overview
15.4.5 F. Hoffman-La Roche Recent Developments
15.5 GlaxoSmithKline
15.5.1 GlaxoSmithKline Basic Information
15.5.2 GlaxoSmithKline Parkinson’s Disease Therapeutics Product Overview
15.5.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Product Market Performance
15.5.4 GlaxoSmithKline Business Overview
15.5.5 GlaxoSmithKline Recent Developments
15.6 H. Lundbeck A/S
15.6.1 H. Lundbeck A/S Basic Information
15.6.2 H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Overview
15.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Market Performance
15.6.4 H. Lundbeck A/S Business Overview
15.6.5 H. Lundbeck A/S Recent Developments
15.7 Impax Labs
15.7.1 Impax Labs Basic Information
15.7.2 Impax Labs Parkinson’s Disease Therapeutics Product Overview
15.7.3 Impax Labs Parkinson’s Disease Therapeutics Product Market Performance
15.7.4 Impax Labs Business Overview
15.7.5 Impax Labs Recent Developments
15.8 Newron Pharmaceuticals SpA
15.8.1 Newron Pharmaceuticals SpA Basic Information
15.8.2 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Overview
15.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Market Performance
15.8.4 Newron Pharmaceuticals SpA Business Overview
15.8.5 Newron Pharmaceuticals SpA Recent Developments
15.9 Novartis AG
15.9.1 Novartis AG Basic Information
15.9.2 Novartis AG Parkinson’s Disease Therapeutics Product Overview
15.9.3 Novartis AG Parkinson’s Disease Therapeutics Product Market Performance
15.9.4 Novartis AG Business Overview
15.9.5 Novartis AG Recent Developments
15.10 Orion Corporation
15.10.1 Orion Corporation Basic Information
15.10.2 Orion Corporation Parkinson’s Disease Therapeutics Product Overview
15.10.3 Orion Corporation Parkinson’s Disease Therapeutics Product Market Performance
15.10.4 Orion Corporation Business Overview
15.10.5 Orion Corporation Recent Developments
15.11 Teva Pharmaceutical Industries Ltd.
15.11.1 Teva Pharmaceutical Industries Ltd. Basic Information
15.11.2 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Overview
15.11.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Market Performance
15.11.4 Teva Pharmaceutical Industries Ltd. Business Overview
15.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments
15.12 UCB S.A.
15.12.1 UCB S.A. Basic Information
15.12.2 UCB S.A. Parkinson’s Disease Therapeutics Product Overview
15.12.3 UCB S.A. Parkinson’s Disease Therapeutics Product Market Performance
15.12.4 UCB S.A. Business Overview
15.12.5 UCB S.A. Recent Developments
15.13 Livzon Pharmaceutical
15.13.1 Livzon Pharmaceutical Basic Information
15.13.2 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
15.13.3 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Market Performance
15.13.4 Livzon Pharmaceutical Business Overview
15.13.5 Livzon Pharmaceutical Recent Developments
15.14 Haisco Pharmaceutical
15.14.1 Haisco Pharmaceutical Basic Information
15.14.2 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
15.14.3 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Market Performance
15.14.4 Haisco Pharmaceutical Business Overview
15.14.5 Haisco Pharmaceutical Recent Developments
15.15 Jingxin Pharmaceutical
15.15.1 Jingxin Pharmaceutical Basic Information
15.15.2 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
15.15.3 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Market Performance
15.15.4 Jingxin Pharmaceutical Business Overview
15.15.5 Jingxin Pharmaceutical Recent Developments
15.16 Dongcheng Biochemicals
15.16.1 Dongcheng Biochemicals Basic Information
15.16.2 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Overview
15.16.3 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Market Performance
15.16.4 Dongcheng Biochemicals Business Overview
15.16.5 Dongcheng Biochemicals Recent Developments
16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Parkinson’s Disease Therapeutics Market Size by Type (M USD)
Table 4. Global Parkinson’s Disease Therapeutics Market Size by Application (M USD)
Table 5. Parkinson’s Disease Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Parkinson’s Disease Therapeutics Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Parkinson’s Disease Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Parkinson’s Disease Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Parkinson’s Disease Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2024)
Table 11. Global Market Parkinson’s Disease Therapeutics Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Parkinson’s Disease Therapeutics Manufacturing Sites and Area Served
Table 13. Manufacturers Parkinson’s Disease Therapeutics Product Type
Table 14. Global Parkinson’s Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinson’s Disease Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Parkinson’s Disease Therapeutics Market Size Comparison by Region (M USD)
Table 26. Global Parkinson’s Disease Therapeutics Market Size by Region (2020-2033) & (M USD)
Table 27. Global Parkinson’s Disease Therapeutics Market Size Market Share by Region (2020-2033)
Table 28. Global Parkinson’s Disease Therapeutics Sales by Region (2020-2033) & (K MT)
Table 29. Global Parkinson’s Disease Therapeutics Sales Market Share by Region (2020-2033)
Table 30. North America Parkinson’s Disease Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 31. North America Parkinson’s Disease Therapeutics Sales by Country (2020-2033) & (K MT)
Table 32. North America Parkinson’s Disease Therapeutics Sales by Type (K MT)
Table 33. North America Parkinson’s Disease Therapeutics Market Size by Type (M USD)
Table 34. North America Parkinson’s Disease Therapeutics Sales (K MT) by Type (2020-2033)
Table 35. North America Parkinson’s Disease Therapeutics Market Size (M USD) by Type (2020-2033)
Table 36. North America Parkinson’s Disease Therapeutics Sales by Application (K MT)
Table 37. North America Parkinson’s Disease Therapeutics Market Size by Application (M USD)
Table 38. North America Parkinson’s Disease Therapeutics Sales (K MT) by Application (2020-2033)
Table 39. North America Parkinson’s Disease Therapeutics Market Size (M USD) by Application (2020-2033)
Table 40. Europe Parkinson’s Disease Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Parkinson’s Disease Therapeutics Sales by Country (2020-2033) & (K MT)
Table 42. Europe Parkinson’s Disease Therapeutics Sales by Type (K MT)
Table 43. Europe Parkinson’s Disease Therapeutics Market Size by Type (M USD)
Table 44. Europe Parkinson’s Disease Therapeutics Sales (K MT) by Type (2020-2033)
Table 45. Europe Parkinson’s Disease Therapeutics Market Size (M USD) by Type (2020-2033)
Table 46. Europe Parkinson’s Disease Therapeutics Sales by Application (K MT)
Table 47. Europe Parkinson’s Disease Therapeutics Market Size by Application (M USD)
Table 48. Europe Parkinson’s Disease Therapeutics Sales (K MT) by Application (2020-2033)
Table 49. Europe Parkinson’s Disease Therapeutics Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Parkinson’s Disease Therapeutics Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Parkinson’s Disease Therapeutics Sales by Type (K MT)
Table 53. Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Type (M USD)
Table 54. Asia-Pacific Parkinson’s Disease Therapeutics Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Parkinson’s Disease Therapeutics Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Parkinson’s Disease Therapeutics Sales by Application (K MT)
Table 57. Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Application (M USD)
Table 58. Asia-Pacific Parkinson’s Disease Therapeutics Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Parkinson’s Disease Therapeutics Market Size (M USD) by Application (2020-2025)
Table 60. South America Parkinson’s Disease Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 61. South America Parkinson’s Disease Therapeutics Sales by Country (2020-2033) & (K MT)
Table 62. South America Parkinson’s Disease Therapeutics Sales by Type (K MT)
Table 63. South America Parkinson’s Disease Therapeutics Market Size by Type (M USD)
Table 64. South America Parkinson’s Disease Therapeutics Sales (K MT) by Type (2020-2033)
Table 65. South America Parkinson’s Disease Therapeutics Market Size (M USD) by Type (2020-2033)
Table 66. South America Parkinson’s Disease Therapeutics Sales by Application (K MT)
Table 67. South America Parkinson’s Disease Therapeutics Market Size by Application (M USD)
Table 68. South America Parkinson’s Disease Therapeutics Sales (K MT) by Application (2020-2033)
Table 69. South America Parkinson’s Disease Therapeutics Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Parkinson’s Disease Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Parkinson’s Disease Therapeutics Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Parkinson’s Disease Therapeutics Sales by Type (K MT)
Table 73. Middle East and Africa Parkinson’s Disease Therapeutics Market Size by Type (M USD)
Table 74. Middle East and Africa Parkinson’s Disease Therapeutics Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Parkinson’s Disease Therapeutics Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Parkinson’s Disease Therapeutics Sales by Application (K MT)
Table 77. Middle East and Africa Parkinson’s Disease Therapeutics Market Size by Application (M USD)
Table 78. Middle East and Africa Parkinson’s Disease Therapeutics Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Parkinson’s Disease Therapeutics Market Size (M USD) by Application (2020-2033)
Table 80. Global Parkinson’s Disease Therapeutics Production (K MT) by Region(2020-2025)
Table 81. Global Parkinson’s Disease Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Parkinson’s Disease Therapeutics Revenue Market Share by Region (2020-2025)
Table 83. Global Parkinson’s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Parkinson’s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Parkinson’s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Parkinson’s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Parkinson’s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Parkinson’s Disease Therapeutics Sales by Type (K MT)
Table 89. Global Parkinson’s Disease Therapeutics Market Size by Type (M USD)
Table 90. Global Parkinson’s Disease Therapeutics Sales (K MT) by Type (2020-2033)
Table 91. Global Parkinson’s Disease Therapeutics Sales Market Share by Type (2020-2033)
Table 92. Global Parkinson’s Disease Therapeutics Market Size (M USD) by Type (2020-2033)
Table 93. Global Parkinson’s Disease Therapeutics Market Size Share by Type (2020-2033)
Table 94. Global Parkinson’s Disease Therapeutics Sales (K MT) by Application
Table 95. Global Parkinson’s Disease Therapeutics Market Size by Application(M USD)
Table 96. Global Parkinson’s Disease Therapeutics Sales by Application (2020-2033) & (K MT)
Table 97. Global Parkinson’s Disease Therapeutics Sales Market Share by Application (2020-2033)
Table 98. Global Parkinson’s Disease Therapeutics Market Size by Application (2020-2033) & (M USD)
Table 99. Global Parkinson’s Disease Therapeutics Market Share by Application (2020-2033)
Table 100. Global Parkinson’s Disease Therapeutics Sales Growth Rate by Application (2020-2033)
Table 101. Abbvie Basic Information
Table 102. Abbvie Parkinson’s Disease Therapeutics Product Overview
Table 103. Abbvie Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Abbvie Business Overview
Table 105. Abbvie SWOT Analysis
Table 106. Abbvie Recent Developments
Table 107. Biogen Basic Information
Table 108. Biogen Parkinson’s Disease Therapeutics Product Overview
Table 109. Biogen Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Biogen Business Overview
Table 111. Biogen SWOT Analysis
Table 112. Biogen Recent Developments
Table 113. Boehringer Ingelheim GmbH Basic Information
Table 114. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Overview
Table 115. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Boehringer Ingelheim GmbH Business Overview
Table 117. Boehringer Ingelheim GmbH SWOT Analysis
Table 118. Boehringer Ingelheim GmbH Recent Developments
Table 119. F. Hoffman-La Roche Basic Information
Table 120. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Overview
Table 121. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. F. Hoffman-La Roche Business Overview
Table 123. F. Hoffman-La Roche Recent Developments
Table 124. GlaxoSmithKline Basic Information
Table 125. GlaxoSmithKline Parkinson’s Disease Therapeutics Product Overview
Table 126. GlaxoSmithKline Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. GlaxoSmithKline Business Overview
Table 128. GlaxoSmithKline Recent Developments
Table 129. H. Lundbeck A/S Basic Information
Table 130. H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Overview
Table 131. H. Lundbeck A/S Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. H. Lundbeck A/S Business Overview
Table 133. H. Lundbeck A/S Recent Developments
Table 134. Impax Labs Basic Information
Table 135. Impax Labs Parkinson’s Disease Therapeutics Product Overview
Table 136. Impax Labs Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Impax Labs Business Overview
Table 138. Impax Labs Recent Developments
Table 139. Newron Pharmaceuticals SpA Basic Information
Table 140. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Overview
Table 141. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Newron Pharmaceuticals SpA Business Overview
Table 143. Newron Pharmaceuticals SpA Recent Developments
Table 144. Novartis AG Basic Information
Table 145. Novartis AG Parkinson’s Disease Therapeutics Product Overview
Table 146. Novartis AG Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Novartis AG Business Overview
Table 148. Novartis AG Recent Developments
Table 149. Orion Corporation Basic Information
Table 150. Orion Corporation Parkinson’s Disease Therapeutics Product Overview
Table 151. Orion Corporation Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Orion Corporation Business Overview
Table 153. Orion Corporation Recent Developments
Table 154. Teva Pharmaceutical Industries Ltd. Basic Information
Table 155. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Overview
Table 156. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Teva Pharmaceutical Industries Ltd. Business Overview
Table 158. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 159. UCB S.A. Basic Information
Table 160. UCB S.A. Parkinson’s Disease Therapeutics Product Overview
Table 161. UCB S.A. Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. UCB S.A. Business Overview
Table 163. UCB S.A. Recent Developments
Table 164. Livzon Pharmaceutical Basic Information
Table 165. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
Table 166. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Livzon Pharmaceutical Business Overview
Table 168. Livzon Pharmaceutical Recent Developments
Table 169. Haisco Pharmaceutical Basic Information
Table 170. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
Table 171. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Haisco Pharmaceutical Business Overview
Table 173. Haisco Pharmaceutical Recent Developments
Table 174. Jingxin Pharmaceutical Basic Information
Table 175. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
Table 176. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. Jingxin Pharmaceutical Business Overview
Table 178. Jingxin Pharmaceutical Recent Developments
Table 179. Dongcheng Biochemicals Basic Information
Table 180. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Overview
Table 181. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 182. Dongcheng Biochemicals Business Overview
Table 183. Dongcheng Biochemicals Recent Developments
List of Figures
Figure 1. Product Picture of Parkinson’s Disease Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinson’s Disease Therapeutics Market Size (M USD), 2024-2033
Figure 5. Global Parkinson’s Disease Therapeutics Market Size (M USD) (2020-2033)
Figure 6. Global Parkinson’s Disease Therapeutics Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinson’s Disease Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Parkinson’s Disease Therapeutics Product Life Cycle
Figure 13. Parkinson’s Disease Therapeutics Sales Share by Manufacturers in 2024
Figure 14. Global Parkinson’s Disease Therapeutics Revenue Share by Manufacturers in 2024
Figure 15. Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Parkinson’s Disease Therapeutics Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Parkinson’s Disease Therapeutics Revenue in 2024
Figure 18. Industry Chain Map of Parkinson’s Disease Therapeutics
Figure 19. Global Parkinson’s Disease Therapeutics Market PEST Analysis
Figure 20. Global Parkinson’s Disease Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Parkinson’s Disease Therapeutics Market Size by Region
Figure 27. Global Parkinson’s Disease Therapeutics Market Size Market Share by Region (2020-2033)
Figure 28. Global Parkinson’s Disease Therapeutics Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Parkinson’s Disease Therapeutics Market Size (M USD) by Country
Figure 33. USA Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Parkinson’s Disease Therapeutics Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Parkinson’s Disease Therapeutics Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Parkinson’s Disease Therapeutics Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Parkinson’s Disease Therapeutics Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Parkinson’s Disease Therapeutics Market Size (M USD)by Type
Figure 40. North America Parkinson’s Disease Therapeutics Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Parkinson’s Disease Therapeutics Market Size (M USD) by Country
Figure 45. Germany Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Parkinson’s Disease Therapeutics Market Size (M USD) by Type
Figure 56. Europe Parkinson’s Disease Therapeutics Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Parkinson’s Disease Therapeutics Market Size (M USD) by Country
Figure 61. China Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Parkinson’s Disease Therapeutics Market Size (M USD) by Type
Figure 72. Asia-Pacific Parkinson’s Disease Therapeutics Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Parkinson’s Disease Therapeutics Market Size (M USD) by Country
Figure 77. Brazil Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Parkinson’s Disease Therapeutics Market Size (M USD) by Type
Figure 84. South America Parkinson’s Disease Therapeutics Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Parkinson’s Disease Therapeutics Market Size (M USD) by Country
Figure 89. Saudi Arabia Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Parkinson’s Disease Therapeutics Market Size (M USD) by Type
Figure 100. Middle East and Africa Parkinson’s Disease Therapeutics Market Size (M USD) by Application
Figure 101. Global Parkinson’s Disease Therapeutics Production Market Share by Region (2020-2025)
Figure 102. North America Parkinson’s Disease Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Parkinson’s Disease Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Parkinson’s Disease Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 105. China Parkinson’s Disease Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Parkinson’s Disease Therapeutics Market Size by Type (M USD)
Figure 108. Sales Market Share of Parkinson’s Disease Therapeutics by Type (2020-2033)
Figure 109. Sales Market Share of Parkinson’s Disease Therapeutics by Type in 2024
Figure 110. Market Size Share of Parkinson’s Disease Therapeutics by Type (2020-2033)
Figure 111. Market Size Share of Parkinson’s Disease Therapeutics by Type in 2024
Figure 112. Global Parkinson’s Disease Therapeutics Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Parkinson’s Disease Therapeutics Market Size by Application(M USD)
Figure 115. Global Parkinson’s Disease Therapeutics Market Share by Application
Figure 116. Global Parkinson’s Disease Therapeutics Sales Market Share by Application (2020-2033)
Figure 117. Global Parkinson’s Disease Therapeutics Sales Market Share by Application in 2024
Figure 118. Global Parkinson’s Disease Therapeutics Market Share by Application (2020-2033)
Figure 119. Global Parkinson’s Disease Therapeutics Market Share by Application in 2024
Figure 120. Global Parkinson’s Disease Therapeutics Sales Growth Rate by Application (2020-2033)
1.1 Market Definition and Statistical Scope of Parkinson’s Disease Therapeutics
1.2 Key Market Segments
1.2.1 Parkinson’s Disease Therapeutics Segment by Type
1.2.2 Parkinson’s Disease Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLOBAL PARKINSON’S DISEASE THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Parkinson’s Disease Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Parkinson’s Disease Therapeutics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLOBAL PARKINSON’S DISEASE THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Parkinson’s Disease Therapeutics Product Life Cycle
3.3 Global Parkinson’s Disease Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Parkinson’s Disease Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Parkinson’s Disease Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Parkinson’s Disease Therapeutics Manufacturing Sites, Area Served, Product Type
3.8 Parkinson’s Disease Therapeutics Market Competitive Situation and Trends
3.8.1 Parkinson’s Disease Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Parkinson’s Disease Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PARKINSON’S DISEASE THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Parkinson’s Disease Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PARKINSON’S DISEASE THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Parkinson’s Disease Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Parkinson’s Disease Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 GLOBAL PARKINSON’S DISEASE THERAPEUTICS MARKET BY REGION
6.1 Global Parkinson’s Disease Therapeutics Market Size by Region
6.1.1 Global Parkinson’s Disease Therapeutics Market Size by Region
6.1.2 Global Parkinson’s Disease Therapeutics Market Size Market Share by Region
6.2 Global Parkinson’s Disease Therapeutics Sales by Region
6.2.1 Global Parkinson’s Disease Therapeutics Sales by Region
6.2.2 Global Parkinson’s Disease Therapeutics Sales Market Share by Region
7 NORTH AMERICA MARKET OVERVIEW
7.1 North America Parkinson’s Disease Therapeutics Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Parkinson’s Disease Therapeutics Market Size by Type
7.3 North America Parkinson’s Disease Therapeutics Market Size by Application
8 EUROPE MARKET OVERVIEW
8.1 Europe Parkinson’s Disease Therapeutics Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Parkinson’s Disease Therapeutics Market Size by Type
8.3 Europe Parkinson’s Disease Therapeutics Market Size by Application
9 ASIA-PACIFIC MARKET OVERVIEW
9.1 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Type
9.3 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Application
10 SOUTH AMERICA MARKET OVERVIEW
10.1 South America Parkinson’s Disease Therapeutics Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Parkinson’s Disease Therapeutics Market Size by Type
10.3 South America Parkinson’s Disease Therapeutics Market Size by Application
11 MIDDLE EAST AND AFRICA MARKET OVERVIEW
11.1 Middle East and Africa Parkinson’s Disease Therapeutics Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Parkinson’s Disease Therapeutics Market Size by Type
11.3 Middle East and Africa Parkinson’s Disease Therapeutics Market Size by Application
12 PARKINSON’S DISEASE THERAPEUTICS MARKET PRODUCTION BY REGION
12.1 Global Production of Parkinson’s Disease Therapeutics by Region(2020-2025)
12.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Region (2020-2025)
12.3 Global Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Parkinson’s Disease Therapeutics Production
12.4.1 North America Parkinson’s Disease Therapeutics Production Growth Rate (2020-2025)
12.4.2 North America Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Parkinson’s Disease Therapeutics Production
12.5.1 Europe Parkinson’s Disease Therapeutics Production Growth Rate (2020-2025)
12.5.2 Europe Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Parkinson’s Disease Therapeutics Production (2020-2025)
12.6.1 Japan Parkinson’s Disease Therapeutics Production Growth Rate (2020-2025)
12.6.2 Japan Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Parkinson’s Disease Therapeutics Production (2020-2025)
12.7.1 China Parkinson’s Disease Therapeutics Production Growth Rate (2020-2025)
12.7.2 China Parkinson’s Disease Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
13 PARKINSON’S DISEASE THERAPEUTICS MARKET SEGMENTATION BY TYPE
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Parkinson’s Disease Therapeutics Sales Market Share by Type (2020-2033)
13.3 Global Parkinson’s Disease Therapeutics Market Size Market Share by Type (2020-2033)
13.4 Global Parkinson’s Disease Therapeutics Price by Type (2020-2033)
14 PARKINSON’S DISEASE THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Parkinson’s Disease Therapeutics Market Sales by Application (2020-2033)
14.3 Global Parkinson’s Disease Therapeutics Market Size (M USD) by Application (2020-2033)
14.4 Global Parkinson’s Disease Therapeutics Sales Growth Rate by Application (2020-2033)
15 KEY COMPANIES PROFILE
15.1 Abbvie
15.1.1 Abbvie Basic Information
15.1.2 Abbvie Parkinson’s Disease Therapeutics Product Overview
15.1.3 Abbvie Parkinson’s Disease Therapeutics Product Market Performance
15.1.4 Abbvie Business Overview
15.1.5 Abbvie SWOT Analysis
15.1.6 Abbvie Recent Developments
15.2 Biogen
15.2.1 Biogen Basic Information
15.2.2 Biogen Parkinson’s Disease Therapeutics Product Overview
15.2.3 Biogen Parkinson’s Disease Therapeutics Product Market Performance
15.2.4 Biogen Business Overview
15.2.5 Biogen SWOT Analysis
15.2.6 Biogen Recent Developments
15.3 Boehringer Ingelheim GmbH
15.3.1 Boehringer Ingelheim GmbH Basic Information
15.3.2 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Overview
15.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Market Performance
15.3.4 Boehringer Ingelheim GmbH Business Overview
15.3.5 Boehringer Ingelheim GmbH SWOT Analysis
15.3.6 Boehringer Ingelheim GmbH Recent Developments
15.4 F. Hoffman-La Roche
15.4.1 F. Hoffman-La Roche Basic Information
15.4.2 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Overview
15.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Market Performance
15.4.4 F. Hoffman-La Roche Business Overview
15.4.5 F. Hoffman-La Roche Recent Developments
15.5 GlaxoSmithKline
15.5.1 GlaxoSmithKline Basic Information
15.5.2 GlaxoSmithKline Parkinson’s Disease Therapeutics Product Overview
15.5.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Product Market Performance
15.5.4 GlaxoSmithKline Business Overview
15.5.5 GlaxoSmithKline Recent Developments
15.6 H. Lundbeck A/S
15.6.1 H. Lundbeck A/S Basic Information
15.6.2 H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Overview
15.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Market Performance
15.6.4 H. Lundbeck A/S Business Overview
15.6.5 H. Lundbeck A/S Recent Developments
15.7 Impax Labs
15.7.1 Impax Labs Basic Information
15.7.2 Impax Labs Parkinson’s Disease Therapeutics Product Overview
15.7.3 Impax Labs Parkinson’s Disease Therapeutics Product Market Performance
15.7.4 Impax Labs Business Overview
15.7.5 Impax Labs Recent Developments
15.8 Newron Pharmaceuticals SpA
15.8.1 Newron Pharmaceuticals SpA Basic Information
15.8.2 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Overview
15.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Market Performance
15.8.4 Newron Pharmaceuticals SpA Business Overview
15.8.5 Newron Pharmaceuticals SpA Recent Developments
15.9 Novartis AG
15.9.1 Novartis AG Basic Information
15.9.2 Novartis AG Parkinson’s Disease Therapeutics Product Overview
15.9.3 Novartis AG Parkinson’s Disease Therapeutics Product Market Performance
15.9.4 Novartis AG Business Overview
15.9.5 Novartis AG Recent Developments
15.10 Orion Corporation
15.10.1 Orion Corporation Basic Information
15.10.2 Orion Corporation Parkinson’s Disease Therapeutics Product Overview
15.10.3 Orion Corporation Parkinson’s Disease Therapeutics Product Market Performance
15.10.4 Orion Corporation Business Overview
15.10.5 Orion Corporation Recent Developments
15.11 Teva Pharmaceutical Industries Ltd.
15.11.1 Teva Pharmaceutical Industries Ltd. Basic Information
15.11.2 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Overview
15.11.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Market Performance
15.11.4 Teva Pharmaceutical Industries Ltd. Business Overview
15.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments
15.12 UCB S.A.
15.12.1 UCB S.A. Basic Information
15.12.2 UCB S.A. Parkinson’s Disease Therapeutics Product Overview
15.12.3 UCB S.A. Parkinson’s Disease Therapeutics Product Market Performance
15.12.4 UCB S.A. Business Overview
15.12.5 UCB S.A. Recent Developments
15.13 Livzon Pharmaceutical
15.13.1 Livzon Pharmaceutical Basic Information
15.13.2 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
15.13.3 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Market Performance
15.13.4 Livzon Pharmaceutical Business Overview
15.13.5 Livzon Pharmaceutical Recent Developments
15.14 Haisco Pharmaceutical
15.14.1 Haisco Pharmaceutical Basic Information
15.14.2 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
15.14.3 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Market Performance
15.14.4 Haisco Pharmaceutical Business Overview
15.14.5 Haisco Pharmaceutical Recent Developments
15.15 Jingxin Pharmaceutical
15.15.1 Jingxin Pharmaceutical Basic Information
15.15.2 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
15.15.3 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Market Performance
15.15.4 Jingxin Pharmaceutical Business Overview
15.15.5 Jingxin Pharmaceutical Recent Developments
15.16 Dongcheng Biochemicals
15.16.1 Dongcheng Biochemicals Basic Information
15.16.2 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Overview
15.16.3 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Market Performance
15.16.4 Dongcheng Biochemicals Business Overview
15.16.5 Dongcheng Biochemicals Recent Developments
16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Parkinson’s Disease Therapeutics Market Size by Type (M USD)
Table 4. Global Parkinson’s Disease Therapeutics Market Size by Application (M USD)
Table 5. Parkinson’s Disease Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Parkinson’s Disease Therapeutics Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Parkinson’s Disease Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Parkinson’s Disease Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Parkinson’s Disease Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2024)
Table 11. Global Market Parkinson’s Disease Therapeutics Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Parkinson’s Disease Therapeutics Manufacturing Sites and Area Served
Table 13. Manufacturers Parkinson’s Disease Therapeutics Product Type
Table 14. Global Parkinson’s Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinson’s Disease Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Parkinson’s Disease Therapeutics Market Size Comparison by Region (M USD)
Table 26. Global Parkinson’s Disease Therapeutics Market Size by Region (2020-2033) & (M USD)
Table 27. Global Parkinson’s Disease Therapeutics Market Size Market Share by Region (2020-2033)
Table 28. Global Parkinson’s Disease Therapeutics Sales by Region (2020-2033) & (K MT)
Table 29. Global Parkinson’s Disease Therapeutics Sales Market Share by Region (2020-2033)
Table 30. North America Parkinson’s Disease Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 31. North America Parkinson’s Disease Therapeutics Sales by Country (2020-2033) & (K MT)
Table 32. North America Parkinson’s Disease Therapeutics Sales by Type (K MT)
Table 33. North America Parkinson’s Disease Therapeutics Market Size by Type (M USD)
Table 34. North America Parkinson’s Disease Therapeutics Sales (K MT) by Type (2020-2033)
Table 35. North America Parkinson’s Disease Therapeutics Market Size (M USD) by Type (2020-2033)
Table 36. North America Parkinson’s Disease Therapeutics Sales by Application (K MT)
Table 37. North America Parkinson’s Disease Therapeutics Market Size by Application (M USD)
Table 38. North America Parkinson’s Disease Therapeutics Sales (K MT) by Application (2020-2033)
Table 39. North America Parkinson’s Disease Therapeutics Market Size (M USD) by Application (2020-2033)
Table 40. Europe Parkinson’s Disease Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Parkinson’s Disease Therapeutics Sales by Country (2020-2033) & (K MT)
Table 42. Europe Parkinson’s Disease Therapeutics Sales by Type (K MT)
Table 43. Europe Parkinson’s Disease Therapeutics Market Size by Type (M USD)
Table 44. Europe Parkinson’s Disease Therapeutics Sales (K MT) by Type (2020-2033)
Table 45. Europe Parkinson’s Disease Therapeutics Market Size (M USD) by Type (2020-2033)
Table 46. Europe Parkinson’s Disease Therapeutics Sales by Application (K MT)
Table 47. Europe Parkinson’s Disease Therapeutics Market Size by Application (M USD)
Table 48. Europe Parkinson’s Disease Therapeutics Sales (K MT) by Application (2020-2033)
Table 49. Europe Parkinson’s Disease Therapeutics Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Parkinson’s Disease Therapeutics Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Parkinson’s Disease Therapeutics Sales by Type (K MT)
Table 53. Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Type (M USD)
Table 54. Asia-Pacific Parkinson’s Disease Therapeutics Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Parkinson’s Disease Therapeutics Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Parkinson’s Disease Therapeutics Sales by Application (K MT)
Table 57. Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Application (M USD)
Table 58. Asia-Pacific Parkinson’s Disease Therapeutics Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Parkinson’s Disease Therapeutics Market Size (M USD) by Application (2020-2025)
Table 60. South America Parkinson’s Disease Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 61. South America Parkinson’s Disease Therapeutics Sales by Country (2020-2033) & (K MT)
Table 62. South America Parkinson’s Disease Therapeutics Sales by Type (K MT)
Table 63. South America Parkinson’s Disease Therapeutics Market Size by Type (M USD)
Table 64. South America Parkinson’s Disease Therapeutics Sales (K MT) by Type (2020-2033)
Table 65. South America Parkinson’s Disease Therapeutics Market Size (M USD) by Type (2020-2033)
Table 66. South America Parkinson’s Disease Therapeutics Sales by Application (K MT)
Table 67. South America Parkinson’s Disease Therapeutics Market Size by Application (M USD)
Table 68. South America Parkinson’s Disease Therapeutics Sales (K MT) by Application (2020-2033)
Table 69. South America Parkinson’s Disease Therapeutics Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Parkinson’s Disease Therapeutics Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Parkinson’s Disease Therapeutics Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Parkinson’s Disease Therapeutics Sales by Type (K MT)
Table 73. Middle East and Africa Parkinson’s Disease Therapeutics Market Size by Type (M USD)
Table 74. Middle East and Africa Parkinson’s Disease Therapeutics Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Parkinson’s Disease Therapeutics Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Parkinson’s Disease Therapeutics Sales by Application (K MT)
Table 77. Middle East and Africa Parkinson’s Disease Therapeutics Market Size by Application (M USD)
Table 78. Middle East and Africa Parkinson’s Disease Therapeutics Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Parkinson’s Disease Therapeutics Market Size (M USD) by Application (2020-2033)
Table 80. Global Parkinson’s Disease Therapeutics Production (K MT) by Region(2020-2025)
Table 81. Global Parkinson’s Disease Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Parkinson’s Disease Therapeutics Revenue Market Share by Region (2020-2025)
Table 83. Global Parkinson’s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Parkinson’s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Parkinson’s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Parkinson’s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Parkinson’s Disease Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Parkinson’s Disease Therapeutics Sales by Type (K MT)
Table 89. Global Parkinson’s Disease Therapeutics Market Size by Type (M USD)
Table 90. Global Parkinson’s Disease Therapeutics Sales (K MT) by Type (2020-2033)
Table 91. Global Parkinson’s Disease Therapeutics Sales Market Share by Type (2020-2033)
Table 92. Global Parkinson’s Disease Therapeutics Market Size (M USD) by Type (2020-2033)
Table 93. Global Parkinson’s Disease Therapeutics Market Size Share by Type (2020-2033)
Table 94. Global Parkinson’s Disease Therapeutics Sales (K MT) by Application
Table 95. Global Parkinson’s Disease Therapeutics Market Size by Application(M USD)
Table 96. Global Parkinson’s Disease Therapeutics Sales by Application (2020-2033) & (K MT)
Table 97. Global Parkinson’s Disease Therapeutics Sales Market Share by Application (2020-2033)
Table 98. Global Parkinson’s Disease Therapeutics Market Size by Application (2020-2033) & (M USD)
Table 99. Global Parkinson’s Disease Therapeutics Market Share by Application (2020-2033)
Table 100. Global Parkinson’s Disease Therapeutics Sales Growth Rate by Application (2020-2033)
Table 101. Abbvie Basic Information
Table 102. Abbvie Parkinson’s Disease Therapeutics Product Overview
Table 103. Abbvie Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Abbvie Business Overview
Table 105. Abbvie SWOT Analysis
Table 106. Abbvie Recent Developments
Table 107. Biogen Basic Information
Table 108. Biogen Parkinson’s Disease Therapeutics Product Overview
Table 109. Biogen Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Biogen Business Overview
Table 111. Biogen SWOT Analysis
Table 112. Biogen Recent Developments
Table 113. Boehringer Ingelheim GmbH Basic Information
Table 114. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Overview
Table 115. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Boehringer Ingelheim GmbH Business Overview
Table 117. Boehringer Ingelheim GmbH SWOT Analysis
Table 118. Boehringer Ingelheim GmbH Recent Developments
Table 119. F. Hoffman-La Roche Basic Information
Table 120. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Overview
Table 121. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. F. Hoffman-La Roche Business Overview
Table 123. F. Hoffman-La Roche Recent Developments
Table 124. GlaxoSmithKline Basic Information
Table 125. GlaxoSmithKline Parkinson’s Disease Therapeutics Product Overview
Table 126. GlaxoSmithKline Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. GlaxoSmithKline Business Overview
Table 128. GlaxoSmithKline Recent Developments
Table 129. H. Lundbeck A/S Basic Information
Table 130. H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Overview
Table 131. H. Lundbeck A/S Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. H. Lundbeck A/S Business Overview
Table 133. H. Lundbeck A/S Recent Developments
Table 134. Impax Labs Basic Information
Table 135. Impax Labs Parkinson’s Disease Therapeutics Product Overview
Table 136. Impax Labs Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Impax Labs Business Overview
Table 138. Impax Labs Recent Developments
Table 139. Newron Pharmaceuticals SpA Basic Information
Table 140. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Overview
Table 141. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Newron Pharmaceuticals SpA Business Overview
Table 143. Newron Pharmaceuticals SpA Recent Developments
Table 144. Novartis AG Basic Information
Table 145. Novartis AG Parkinson’s Disease Therapeutics Product Overview
Table 146. Novartis AG Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Novartis AG Business Overview
Table 148. Novartis AG Recent Developments
Table 149. Orion Corporation Basic Information
Table 150. Orion Corporation Parkinson’s Disease Therapeutics Product Overview
Table 151. Orion Corporation Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Orion Corporation Business Overview
Table 153. Orion Corporation Recent Developments
Table 154. Teva Pharmaceutical Industries Ltd. Basic Information
Table 155. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Overview
Table 156. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Teva Pharmaceutical Industries Ltd. Business Overview
Table 158. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 159. UCB S.A. Basic Information
Table 160. UCB S.A. Parkinson’s Disease Therapeutics Product Overview
Table 161. UCB S.A. Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. UCB S.A. Business Overview
Table 163. UCB S.A. Recent Developments
Table 164. Livzon Pharmaceutical Basic Information
Table 165. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
Table 166. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Livzon Pharmaceutical Business Overview
Table 168. Livzon Pharmaceutical Recent Developments
Table 169. Haisco Pharmaceutical Basic Information
Table 170. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
Table 171. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Haisco Pharmaceutical Business Overview
Table 173. Haisco Pharmaceutical Recent Developments
Table 174. Jingxin Pharmaceutical Basic Information
Table 175. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Overview
Table 176. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. Jingxin Pharmaceutical Business Overview
Table 178. Jingxin Pharmaceutical Recent Developments
Table 179. Dongcheng Biochemicals Basic Information
Table 180. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Overview
Table 181. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 182. Dongcheng Biochemicals Business Overview
Table 183. Dongcheng Biochemicals Recent Developments
List of Figures
Figure 1. Product Picture of Parkinson’s Disease Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinson’s Disease Therapeutics Market Size (M USD), 2024-2033
Figure 5. Global Parkinson’s Disease Therapeutics Market Size (M USD) (2020-2033)
Figure 6. Global Parkinson’s Disease Therapeutics Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinson’s Disease Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Parkinson’s Disease Therapeutics Product Life Cycle
Figure 13. Parkinson’s Disease Therapeutics Sales Share by Manufacturers in 2024
Figure 14. Global Parkinson’s Disease Therapeutics Revenue Share by Manufacturers in 2024
Figure 15. Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Parkinson’s Disease Therapeutics Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Parkinson’s Disease Therapeutics Revenue in 2024
Figure 18. Industry Chain Map of Parkinson’s Disease Therapeutics
Figure 19. Global Parkinson’s Disease Therapeutics Market PEST Analysis
Figure 20. Global Parkinson’s Disease Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Parkinson’s Disease Therapeutics Market Size by Region
Figure 27. Global Parkinson’s Disease Therapeutics Market Size Market Share by Region (2020-2033)
Figure 28. Global Parkinson’s Disease Therapeutics Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Parkinson’s Disease Therapeutics Market Size (M USD) by Country
Figure 33. USA Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Parkinson’s Disease Therapeutics Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Parkinson’s Disease Therapeutics Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Parkinson’s Disease Therapeutics Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Parkinson’s Disease Therapeutics Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Parkinson’s Disease Therapeutics Market Size (M USD)by Type
Figure 40. North America Parkinson’s Disease Therapeutics Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Parkinson’s Disease Therapeutics Market Size (M USD) by Country
Figure 45. Germany Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Parkinson’s Disease Therapeutics Market Size (M USD) by Type
Figure 56. Europe Parkinson’s Disease Therapeutics Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Parkinson’s Disease Therapeutics Market Size (M USD) by Country
Figure 61. China Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Parkinson’s Disease Therapeutics Market Size (M USD) by Type
Figure 72. Asia-Pacific Parkinson’s Disease Therapeutics Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Parkinson’s Disease Therapeutics Market Size (M USD) by Country
Figure 77. Brazil Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Parkinson’s Disease Therapeutics Market Size (M USD) by Type
Figure 84. South America Parkinson’s Disease Therapeutics Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Parkinson’s Disease Therapeutics Market Size (M USD) by Country
Figure 89. Saudi Arabia Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Parkinson’s Disease Therapeutics Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Parkinson’s Disease Therapeutics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Parkinson’s Disease Therapeutics Market Size (M USD) by Type
Figure 100. Middle East and Africa Parkinson’s Disease Therapeutics Market Size (M USD) by Application
Figure 101. Global Parkinson’s Disease Therapeutics Production Market Share by Region (2020-2025)
Figure 102. North America Parkinson’s Disease Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Parkinson’s Disease Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Parkinson’s Disease Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 105. China Parkinson’s Disease Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Parkinson’s Disease Therapeutics Market Size by Type (M USD)
Figure 108. Sales Market Share of Parkinson’s Disease Therapeutics by Type (2020-2033)
Figure 109. Sales Market Share of Parkinson’s Disease Therapeutics by Type in 2024
Figure 110. Market Size Share of Parkinson’s Disease Therapeutics by Type (2020-2033)
Figure 111. Market Size Share of Parkinson’s Disease Therapeutics by Type in 2024
Figure 112. Global Parkinson’s Disease Therapeutics Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Parkinson’s Disease Therapeutics Market Size by Application(M USD)
Figure 115. Global Parkinson’s Disease Therapeutics Market Share by Application
Figure 116. Global Parkinson’s Disease Therapeutics Sales Market Share by Application (2020-2033)
Figure 117. Global Parkinson’s Disease Therapeutics Sales Market Share by Application in 2024
Figure 118. Global Parkinson’s Disease Therapeutics Market Share by Application (2020-2033)
Figure 119. Global Parkinson’s Disease Therapeutics Market Share by Application in 2024
Figure 120. Global Parkinson’s Disease Therapeutics Sales Growth Rate by Application (2020-2033)
